Gapping up
In reaction to earnings/guidance:
- SOFI +8.6%, PHG +5.4%, CINF +0.8%
Other news:
- GMVD +101.7% (announced that it has received a patent issue notification from the United States Patent and Trademark Office for its monitoring products marketed in the United States)
- ARLP +12.3% (increases its quarterly distribution by 40% to $0.70/unit; also reported earnings)
- SCLX +10% (Sorrento Issues "FAQ" Regarding the Dividend of Scilex Holding Company (SCLX) Common Stock)
- MLEC +6.2% (files for 35865887 share common stock offering by selling shareholders; relates to warrants)
- EVOK +4.2% (announces joint stipulation of dismissal in GIMOTI patent infringement case against Teva Pharma)
- XERS +4% (FDA granted its subsidiary Xeris Pharmaceuticals orphan-drug exclusivity for Recorlev)
- VZLA +3.1% (upsizes private placement financing to $39 mln)
- GH +1.6% (receives FDA approval for Guardant360 CDx as companion diagnostic for Menarini Group's ORSERDU for treatment of patients with ESR1 mutations in ER+ HER2- advanced or metastatic breast cancer)
Analyst comments:
- FLS +1.1% (upgraded to Buy from Neutral at BofA Securities)
- CL +1% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- LMT +0.5% (upgraded to Buy from Hold at DZ Bank)